相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unravelling the Proteomics of HLA-B*57:01+ Antigen Presenting Cells during Abacavir Medication
Funmilola Josephine Haukamp et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A*32:01-positive vancomycin-induced DRESS sharing an HLA class II haplotype
Nontaya Nakkam et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions
Yueran Li et al.
FRONTIERS IN GENETICS (2021)
Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions
Pooja Deshpande et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma
Chunxiao Qi et al.
ONCOLOGY LETTERS (2021)
Role of V-ATPase a3-Subunit in Mouse CTL Function
Praneeth Chitirala et al.
JOURNAL OF IMMUNOLOGY (2020)
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals
Rebecca Pavlos et al.
HUMAN IMMUNOLOGY (2020)
HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues
Gia-Gia T. Ho et al.
IMMUNOGENETICS (2019)
HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint
Gia-Gia T. Ho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Ren-You Pan et al.
NATURE COMMUNICATIONS (2019)
Peripheral Blood RNA Levels of QSOX1 and PLBD1 Are New Independent Predictors of Left Ventricular Dysfunction After Acute Myocardial Infarction
Maarten Vanhaverbeke et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
HLAs: Key regulators of T-cell-mediated drug hypersensitivity
A. J. Redwood et al.
HLA (2018)
Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration
Elizabeth J. Phillips et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
A transgenic mouse model for HLA-B*57: 01-linked abacavir drug tolerance and reactivity
Marco Cardone et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
Bradleigh Whitton et al.
CANCER MEDICINE (2018)
Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B*15:02
Gwendolin S. Simper et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
HLA variation and disease
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2018)
T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma
Hee Doo Yang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
CD68/macrosialin: not just a histochemical marker
Dimitry A. Chistiakov et al.
LABORATORY INVESTIGATION (2017)
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions
Patricia T. Illing et al.
IMMUNOGENETICS (2017)
The non-canonical NF-κB pathway in immunity and inflammation
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2017)
Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms
Werner J. Pichler et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
ZFP91: A Noncanonical NF-κB Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer
Lukasz Paschke et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Soluble CD14 is a nonspecific marker of monocyte activation
Carey L. Shive et al.
AIDS (2015)
High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression
Evguenia Krastinova et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
Michal Bassani-Sternberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution
Trushar R. Patel et al.
MATRIX BIOLOGY (2014)
A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A*24 Allotypes
Soumya Badrinath et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Abacavir Pharmacogenetics - From Initial Reports to Standard of Care
Michael A. Martin et al.
PHARMACOTHERAPY (2013)
Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross et al.
AIDS (2012)
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Patricia T. Illing et al.
NATURE (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pocketcheck: updating the HLA class I peptide specificity roadmap
T. Huyton et al.
TISSUE ANTIGENS (2012)
Delayed drug hypersensitivity: models of T-cell stimulation
Jacqueline Adam et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B(star)41 allotypic family
Christina Bade-Doeding et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Deletion of the murine scavenger receptor CD68
Li Song et al.
JOURNAL OF LIPID RESEARCH (2011)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
A quantitative real time PCR method to analyze T cell receptor Vβ subgroup expansion by staphylococcal superantigens
Keun Seok Seo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
ZAP70: a master regulator of adaptive immunity
Alain Fischer et al.
SEMINARS IN IMMUNOPATHOLOGY (2010)
Multiple roles of Lyn kinase in myeloid cell signaling and function
Patrizia Scapini et al.
IMMUNOLOGICAL REVIEWS (2009)
Function of a Subunit Isoforms of the V-ATPase in pH Homeostasis and in Vitro Invasion of MDA-MB231 Human Breast Cancer Cells
Ayana Hinton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
Michael Saag et al.
CLINICAL INFECTIOUS DISEASES (2008)
A review of the pharmacokinetics of abacavir
Geoffrey J. Yuen et al.
CLINICAL PHARMACOKINETICS (2008)
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity
Diana Chessman et al.
IMMUNITY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The molecular basis for public T-cell responses?
Vanessa Venturi et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Structural determinants of T-cell receptor bias in immunity
Stephen J. Turner et al.
NATURE REVIEWS IMMUNOLOGY (2006)
The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation
CL Chu et al.
JOURNAL OF IMMUNOLOGY (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
AM Martin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Delayed drug hypersensitivity reactions
WJ Pichler
ANNALS OF INTERNAL MEDICINE (2003)
MHC class II compartments in human dendritic cells undergo profound structural changes upon activation
N Barois et al.
TRAFFIC (2002)
ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum
T Serwold et al.
NATURE (2002)
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
S Hetherington et al.
LANCET (2002)
Positive and negative regulation of T-cell activation by adaptor proteins
GA Koretzky et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
分享论文
